Healthcare Professionals

Aesculap Biologics, LLC
Healthcare Professionals

Aesculap Biologics, LLC pursues biologic and combination (device/biologic) products to meet the changing needs of the health care environment.

Aesculap Biologics, with its development partner TETEC, AG (based in Reutlingen, Germany), is focused on cartilage repair and regeneration using a collaborative approach with surgeons to uncover unmet medical needs across the world. Within the United States, Aesculap Biologics is currently conducting a Phase 3 trial of NOVOCART® 3D, evaluating efficacy and safety as compared to Microfracture in the repair of articular cartilage of the femoral condyle.

Medical technician looking into microscope
Product Pipeline
NOVOCART 3D

NOVOCART 3D

Matrix Supported Autologous Chondrocyte Transplantation

Learn More
NOVOCART 3D Clinical Trial
NOVOCART 3D Clinical Trial

Become a Part of the NOVOCART 3D Clinical Trial

Do you suffer from knee pain due to a cartilage injury? You may be eligible to participate in a research study of the investigational product NOVOCART 3D, a biologic/device combination product designed to restore damaged knee cartilage.

Learn More